Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosimo Durante

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Current Opinion in Otolaryngology & Head and Neck Surgery|March 5, 2021
Molecular analysis of fine-needle aspiration cytology in thyroid disease: where are we?Giorgio Grani, Marialuisa Sponziello, Sebastiano Filetti, et al.
European Journal of Endocrinology|June 3, 2016
ENDOCRINE TUMOURS: Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approachLivia Lamartina, Désirée Deandreis, Cosimo Durante, et al.
Lancet (London, England)|June 1, 2016
Thyroid cancerMaria E Cabanillas, David G McFadden, Cosimo Durante
Clinical Genetics|August 22, 2019
Molecular defects in thyroid dysgenesisCatia Mio, Giorgio Grani, Cosimo Durante, et al.
Nature Reviews. Endocrinology|August 16, 2024
Thyroid nodules: diagnosis and managementGiorgio Grani, Marialuisa Sponziello, Sebastiano Filetti, et al.
Expert Opinion on Investigational Drugs|February 15, 2011
XL184 (cabozantinib) for medullary thyroid carcinomaCosimo Durante, Diego Russo, Antonella Verrienti, et al.
F1000Research|February 6, 2018
Recent advances in managing differentiated thyroid cancerLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Recenti Progressi in Medicina|June 28, 2008
[Benign thyroid nodules: diagnostic and therapeutic approach]Cosimo Durante, Francesco Cava, Alessandra Paciaroni, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2015
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literatureLivia Lamartina, Cosimo Durante, Sebastiano Filetti, et al.
Journal of Molecular Endocrinology|February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targetsDiego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Current Opinion in Otolaryngology & Head and Neck Surgery|March 5, 2021
Molecular analysis of fine-needle aspiration cytology in thyroid disease: where are we?Giorgio Grani, Marialuisa Sponziello, Sebastiano Filetti, et al.
European Journal of Endocrinology|June 3, 2016
ENDOCRINE TUMOURS: Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approachLivia Lamartina, Désirée Deandreis, Cosimo Durante, et al.
Lancet (London, England)|June 1, 2016
Thyroid cancerMaria E Cabanillas, David G McFadden, Cosimo Durante
Clinical Genetics|August 22, 2019
Molecular defects in thyroid dysgenesisCatia Mio, Giorgio Grani, Cosimo Durante, et al.
Nature Reviews. Endocrinology|August 16, 2024
Thyroid nodules: diagnosis and managementGiorgio Grani, Marialuisa Sponziello, Sebastiano Filetti, et al.
Expert Opinion on Investigational Drugs|February 15, 2011
XL184 (cabozantinib) for medullary thyroid carcinomaCosimo Durante, Diego Russo, Antonella Verrienti, et al.
F1000Research|February 6, 2018
Recent advances in managing differentiated thyroid cancerLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Recenti Progressi in Medicina|June 28, 2008
[Benign thyroid nodules: diagnostic and therapeutic approach]Cosimo Durante, Francesco Cava, Alessandra Paciaroni, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2015
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literatureLivia Lamartina, Cosimo Durante, Sebastiano Filetti, et al.
Journal of Molecular Endocrinology|February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targetsDiego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Pageof 18